1. Home
  2. OXLC vs VOGX Comparison

OXLC vs VOGX Comparison

Compare OXLC & VOGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oxford Lane Capital Corp.

OXLC

Oxford Lane Capital Corp.

N/A

Current Price

$4.92

Market Cap

498.0M

Sector

Finance

ML Signal

N/A

Logo Vogenx Inc Common Stock

VOGX

Vogenx Inc Common Stock

N/A

Current Price

$12.55

Market Cap

482.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OXLC
VOGX
Founded
2010
2021
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
498.0M
482.8M
IPO Year
2010
2026

Fundamental Metrics

Financial Performance
Metric
OXLC
VOGX
Price
$4.92
$12.55
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
★ $6.00
N/A
AVG Volume (30 Days)
★ 2.3M
81.7K
Earning Date
11-01-2023
11-06-2026
Dividend Yield
★ 18.86%
N/A
EPS Growth
N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$136.15
N/A
Revenue Next Year
$5.51
N/A
P/E Ratio
$7.72
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.62
$11.51
52 Week High
$15.39
$38.41

Technical Indicators

Market Signals
Indicator
OXLC
VOGX
Relative Strength Index (RSI) 20.13 33.36
Support Level $4.62 N/A
Resistance Level $10.10 $22.10
Average True Range (ATR) 0.26 2.36
MACD 0.02 -0.61
Stochastic Oscillator 16.14 11.58

Price Performance

Historical Comparison
OXLC
VOGX

About OXLC Oxford Lane Capital Corp.

Oxford Lane Capital Corp is a non-diversified closed-end management investment company. The fund's investment objective is to maximize portfolio's risk adjusted total return, and currently seek to achieve investment objective by investing in structured finance investments, specifically the equity and junior debt tranches of CLO vehicles, which are collateralized by a diverse portfolio of senior secured loans made to companies whose debt is unrated or is rated below investment grade (the Senior Loans) and, to a limited. Its investment plan also includes investing in warehouse facilities, which are financing structures intended to aggregate senior loans that may be used to form the basis of a CLO vehicle.

About VOGX Vogenx Inc Common Stock

Vogenx Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies for the treatment of serious diseases associated with dysfunctions in human metabolism, including post-bariatric hypoglycemia, or PBH, and gastroparesis. The company's flagship product candidate, mizagliflozin, is an orally administered, minimally absorbed, small molecule drug candidate being developed for the treatment of post-bariatric hypoglycemia (PBH), gastroparesis and GIP-induced Cushing's Syndrome. It operates as a single reportable segment engaged in the discovery and development of treatments for serious metabolic and gastrointestinal diseases.

Share on Social Networks: